SEC Form 4 · accession 0000950138-18-000287
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Scholz
Officer — EVP Glob Ops & Pres Spec Gen
Period of report
Apr 1, 2018
Accepted (ET)
Apr 3, 2018 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Apr 1, 2018 | F | 437 | $14.48 | D | 41,194 | D |
Table II — derivative securities
No Table II lines on this filing.